Glucocorticoids in Leprosy Reversal reaction
| Autor: | Renni Yuniati, Matthew Brian Khrisna |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
diagnosis 030231 tropical medicine Neuritis indonesia Type 2 diabetes Dermatology 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Leprosy reversal reaction Pharmacotherapy gene expression profiling Medicine Adverse effect Lepromatous leprosy glucocorticoids business.industry prednisolone medicine.disease comorbidity RL1-803 Leprosy business leprosy |
| Zdroj: | Serbian Journal of Dermatology and Venereology, Vol 11, Iss 3, Pp 77-83 (2019) |
| ISSN: | 2406-0631 1821-0902 |
| Popis: | Leprosy is a disease that is caused by Mycobacterium leprae which results in lots of disabilities in the patients. Leprosy is treated by multi-drug therapy regimen; however, this therapy might cause leprosy reactions in the patients. There are several types of lepromatous reaction: type 1 reaction, type 2 reaction and neuritis. Type 1 reaction mainly occurs in BB, BL and BT forms of leprosy and is characterized by exacerbation of preexisting lesions. The therapy of this reaction according to the WHO guideline is corticosteroid therapy. This article will explain several key points related to the corticosteroid therapy in leprosy reversal reactions, including the side effects and alternative therapies available. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|